COMP <GO>
ULS vs MRK // FORWARD P/E MULTIPLE
UL Solutions Inc. (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: ULS 6
— MRK 9
▲ FORWARD P/E MULTIPLE LEADER: MRK
LAST: $74.76 (-0.93%) • MKT CAP: $15.24B
forward-pe
43.6x
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
forward-pe
18.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ULS VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ULS | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 49.50% | 74.80% | -25.30 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.30% | 20.70% | +7.60 | ULS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 22.4x | 15.3x | +7.10 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 2.65% | 3.42% | -0.77 | MRK | /fcf-yield <GO> |
| Operating Margin | 17.10% | 34.30% | -17.20 | MRK | /operating-margins <GO> |
| Net Profit Margin | 10.60% | 28.10% | -17.50 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | 1.30% | +5.10 | ULS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.68% | 2.26% | -1.58 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.58 | 5.19 | +2.39 | ULS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ULS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.60% | +0.60 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.1 | 56.9 | +4.22 | ULS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.92 | +0.16 | ULS | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 43.6x | 18.4x | +25.20 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.24B | $361.02B | -$345.79B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ULS REV | MRK REV | ULS GROSS % | MRK GROSS % | ULS FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.05B | $65.01B | 49.5% | 74.8% | $403.0M | $12.36B |
| FY 2024 | $2.87B | $64.17B | 48.5% | 76.3% | $287.0M | $18.10B |
| FY 2023 | $2.68B | $60.12B | 44.0% | 44.0% | $346.5M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ULS // BETA 1.08
MRK // BETA 0.92